3.81
XTL Biopharmaceuticals Ltd. ADR
Metrics score locked — part of Premium
FY22
FY23
FY24
FY24
FY25
FY22 – FY25
Assets
(positive)
Change from FY22 to FY25
millions USD
FY22:
FY23:
2.05
FY24:
–
FY24:
1.34
FY25:
0.17
(positive)
Change from FY22 to FY25
millions USD
FY22:
0.38
FY23:
0.38
FY24:
–
FY24:
7.21
FY25:
0
Total assets
Change from FY22 to FY25
millions USD
FY22:
4.19
FY23:
2.43
FY24:
5.84
FY24:
8.55
FY25:
0.17
Liabilities & Equity
(negative)
Change from FY22 to FY25
millions USD
FY22:
0.19
FY23:
0.21
FY24:
–
FY24:
2.21
FY25:
0.42
(negative)
millions USD
FY22:
0
FY23:
0
FY24:
–
FY24:
0.91
FY25:
0
(positive)
Change from FY22 to FY25
millions USD
FY22:
4.00
FY23:
2.22
FY24:
–
FY24:
5.44
FY25:
−0.25
Total liabilities & equity
Change from FY22 to FY25
millions USD
FY22:
4.19
FY23:
2.43
FY24:
–
FY24:
8.55
FY25:
0.17
All amounts in millions USD